Skip to content
Nonprofiteer
← VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC

Form 990 for tax year 2023

Filed by VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC.

Totals

Total revenue
$10,946,946
Total expenses
$11,357,497
Contributions and grants received
$5,836,992
Grants paid
$9,242,529
Program service revenue
$0
Investment income
$4,768,070
Other revenue
$341,884
Total assets, end of year
$133,873,238
Total liabilities, end of year
$1,501,991
Net assets or fund balances, end of year
$132,371,247
Program services expenses (Part IX)
$9,242,529
Management and general expenses
$673,070
Fundraising expenses
$1,441,898
Program service expenses (Part III)
$9,242,529

Program services were 81.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $6,500

  • 1c · Fundraising events

    $336,750

  • 1d · Related organizations

    $3,810,000

  • 1f · All other contributions, gifts and grants

    $1,683,742

  • 1g · Noncash contributions included above

    $300,356

  • 3 · Investment income

    total $3,259,985 · unrelated business -$20,792 · excluded $3,280,777

  • 5 · Royalties

    total $377,678 · excluded $377,678

  • 7a · Gross sales of assets other than inventory

    securities $10,506,170

  • 7b · Less cost or other basis and sales expenses

    securities $8,998,085

  • 7c · Gain or loss

    securities $1,508,085

  • 7d · Net gain or loss

    total $1,508,085 · unrelated business $24,632 · excluded $1,483,453

  • 8a · Fundraising events: gross income

    $63,798

  • 8a · Fundraising events: contributions included on line 1c

    $336,750

  • 8b · Fundraising events: direct expenses

    $99,592

  • 8c · Net income from fundraising events

    total -$35,794 · excluded -$35,794

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $9,242,529 · program services $9,242,529

  • 5 · Compensation of officers, directors and key employees

    total $262,013 · management and general $34,154 · fundraising $227,859

  • 7 · Other salaries and wages

    total $566,710 · management and general $188,565 · fundraising $378,145

  • 8 · Pension plan contributions

    total $29,780 · management and general $11,473 · fundraising $18,307

  • 9 · Other employee benefits

    total $101,044 · management and general $35,125 · fundraising $65,919

  • 10 · Payroll taxes

    total $56,433 · management and general $16,190 · fundraising $40,243

  • 11b · Fees: legal

    total $135,441 · management and general $135,441

  • 11c · Fees: accounting

    total $4,400 · management and general $4,400

  • 11e · Fees: professional fundraising services

    total $441,440 · fundraising $441,440

  • 11f · Fees: investment management

    total $152,186 · management and general $152,186

  • 11g · Fees: other

    total $151,419 · management and general $77 · fundraising $151,342

  • 12 · Advertising and promotion

    total $56,225 · fundraising $56,225

  • 13 · Office expenses

    total $748 · fundraising $748

  • 14 · Information technology

    total $32,419 · management and general $3,250 · fundraising $29,169

  • 15 · Royalties

    total $63,879 · management and general $63,879

  • 16 · Occupancy

    total $1,100 · fundraising $1,100

  • 17 · Travel

    total $5,904 · management and general $240 · fundraising $5,664

  • 19 · Conferences, conventions and meetings

    total $13,743 · management and general $302 · fundraising $13,441

  • 22 · Depreciation, depletion and amortization

    total $4,145 · fundraising $4,145

  • 24a · Other expenses: UBI TAXES

    total $25,781 · management and general $25,781

  • 24b · Other expenses: EQUIPMENT LEASE & MAINT

    total $7,277 · management and general $474 · fundraising $6,803

  • 24c · Other expenses: MEDICAL LAB SUPPLIES

    total $1,653 · management and general $1,653

  • 24d · Other expenses: DUES & MEMBERSHIPS

    total $1,529 · management and general $595 · fundraising $934

  • 24e · All other expenses

    total -$301 · management and general -$715 · fundraising $414

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $0 · end of year $0

  • 2 · Savings and temporary cash investments

    beginning of year $9,180,588 · end of year $4,753,757

  • 3 · Pledges and grants receivable

    beginning of year $1,633,243 · end of year $1,554,665

  • 4 · Accounts receivable

    beginning of year $159,526 · end of year $97,087

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $0 · end of year $0

  • 8 · Inventories for sale or use

    beginning of year $0 · end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $0 · end of year $0

  • 10a · Land, buildings and equipment: cost or other basis

    $54,657

  • 10b · Land, buildings and equipment: accumulated depreciation

    $50,791

  • 10c · Land, buildings and equipment, net

    beginning of year $8,011 · end of year $3,866

  • 11 · Investments: publicly traded securities

    beginning of year $73,994,112 · end of year $90,599,806

  • 12 · Investments: other securities

    beginning of year $38,487,580 · end of year $36,864,057

  • 13 · Investments: program-related

    beginning of year $0 · end of year $0

  • 14 · Intangible assets

    beginning of year $0 · end of year $0

  • 15 · Other assets

    beginning of year $0 · end of year $0

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,144,589 · end of year $1,501,991

  • 18 · Grants payable

    beginning of year $0 · end of year $0

  • 19 · Deferred revenue

    beginning of year $0 · end of year $0

  • 20 · Tax-exempt bond liabilities

    beginning of year $0 · end of year $0

  • 21 · Escrow or custodial account liability

    beginning of year $0 · end of year $0

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $0 · end of year $0

  • 24 · Unsecured notes and loans payable

    beginning of year $0 · end of year $0

  • 25 · Other liabilities

    beginning of year $0 · end of year $0

  • 27 · Net assets without donor restrictions

    beginning of year $114,524,341 · end of year $123,216,504

  • 28 · Net assets with donor restrictions

    beginning of year $7,794,130 · end of year $9,154,743

Mission and programs · 2023

Mission

(SEE SCHEDULE O)

Activities or mission (Part I)

VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION ADVANCES LIFE-SAVING BASIC AND CLINICAL BLOOD RESEARCH.

  • VBRIF SUPPORTS BLOOD RESEARCH RELATED TO TRANSFUSION, TRANSLATIONAL, CLINICAL AND TRANSPLANT MEDICINE.

    Expenses $9,185,204 · Grants $9,185,204

  • VBRIF SUPPORTS THE EFFORTS OF ITS SUPPORTED ORGANIZATIONS, WHICH FURTHER THE IMPORTANT CAUSES OF BLOOD AND ORGAN DONATIONS AND RESEARCH.

    Expenses $57,325 · Grants $57,325

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Chris Miskel

    PRESIDENT & CEO

    Total calculated
    $1,480,476
    From this org
    $0
    From related orgs
    $1,425,101
    Other
    $55,375
    Hours/week
    1 + 54 related

    Schedule J breakdown matched by us

    Base
    $0 + $767,497 related
    Bonus
    $0 + $633,934 related
    Other
    $0 + $23,670 related
    Deferred
    $0 + $22,500 related
    Nontaxable benefits
    $0 + $32,875 related
    Filer's total
    $0 + $1,480,476 related
  • Julia Syburg

    CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Dixon Benz II

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Andy Anderson MD

    SECRETARY

    Total calculated
    $0
    Hours/week
    1
  • Guy Crane

    TREASURER

    Total calculated
    $0
    Hours/week
    1
  • Sam Bradt

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Louise Crowley

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • William Crowley

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Jason Dvorak

    BOARD MEMBER - AS OF 9/2023

    Total calculated
    $0
    Hours/week
    1
  • Fred Geilfuss

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 5 related
  • Emery Harlan

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Thomas Hauske Jr

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 5 related
  • Kathy Klein

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Robert H Manegold

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 5 related
  • Abhishek Pulakanti

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • John R Raymond Sr MD

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Johan Segerdahl

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Suzy Stemper

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Michael H White

    BOARD MEMBER - THRU 6/2023

    Total calculated
    $0
    Hours/week
    1
  • Bart Reuter

    EVP & GENERAL COUNSEL

    Total calculated
    $785,165
    From this org
    $0
    From related orgs
    $720,940
    Other
    $64,225
    Hours/week
    1 + 54 related

    Schedule J breakdown matched by us

    Base
    $0 + $410,935 related
    Bonus
    $0 + $284,861 related
    Other
    $0 + $25,144 related
    Deferred
    $0 + $23,100 related
    Nontaxable benefits
    $0 + $41,125 related
    Filer's total
    $0 + $785,165 related
  • Anthony Watkins

    EVP & CHIEF FINANCIAL OFFICER

    Total calculated
    $781,954
    From this org
    $0
    From related orgs
    $741,823
    Other
    $40,131
    Hours/week
    1 + 54 related

    Schedule J breakdown matched by us

    Base
    $0 + $429,713 related
    Bonus
    $0 + $282,211 related
    Other
    $0 + $29,899 related
    Deferred
    $0 + $23,100 related
    Nontaxable benefits
    $0 + $17,031 related
    Filer's total
    $0 + $781,954 related
  • Michael Deininger MD

    EVP & CHIEF SCIENTIFIC OFFICER

    Total calculated
    $683,113
    From this org
    $32,182
    From related orgs
    $611,478
    Other
    $39,453
    Hours/week
    3 + 52 related

    Schedule J breakdown matched by us

    Base
    $25,305 + $480,803 related
    Bonus
    $5,458 + $103,702 related
    Other
    $1,419 + $26,973 related
    Deferred
    $831 + $15,794 related
    Nontaxable benefits
    $1,141 + $21,687 related
    Filer's total
    $34,154 + $648,959 related
  • Barbara Bryant

    EVP & CHIEF MED OFFICER

    Total calculated
    $571,871
    From this org
    $0
    From related orgs
    $546,023
    Other
    $25,848
    Hours/week
    1 + 54 related

    Schedule J breakdown matched by us

    Base
    $0 + $509,725 related
    Bonus
    $0 + $18,210 related
    Other
    $0 + $18,088 related
    Deferred
    $0 + $23,100 related
    Nontaxable benefits
    $0 + $2,748 related
    Filer's total
    $0 + $571,871 related
  • Kelley McCaskill

    VP OF PHILANTHROPY

    Total calculated
    $227,859
    From this org
    $191,356
    From related orgs
    $0
    Other
    $36,503
    Hours/week
    55

    Schedule J breakdown matched by us

    Base
    $168,046
    Bonus
    $22,040
    Other
    $1,270
    Deferred
    $12,278
    Nontaxable benefits
    $24,225
    Filer's total
    $227,859
  • John Mabry

    DIRECTOR TECH TRANSFER

    Total calculated
    $234,963
    From this org
    $181,451
    From related orgs
    $0
    Other
    $53,512
    Hours/week
    55

    Schedule J breakdown matched by us

    Base
    $174,656
    Bonus
    $6,200
    Other
    $595
    Deferred
    $13,049
    Nontaxable benefits
    $40,463
    Filer's total
    $234,963
  • Alberto G Huerta

    DIRECTOR FDN DEVELOPMENT

    Total calculated
    $125,339
    From this org
    $108,153
    From related orgs
    $0
    Other
    $17,186
    Hours/week
    55

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 3
TOP MANAGEMENT'S COMPENSATION VBRIF DOES NOT DIRECTLY COMPENSATE ITS EMPLOYEES OR OFFICERS; INSTEAD VBRIF RELIES ON ITS RELATED ENTITIES, VERSITI WISCONSIN, INC. AND VERSITI, INC., TO FACILITATE COMPENSATION OF VBRIF EMPLOYEES AND OFFICERS. VERSITI AND ITS AFFILIATED BLOOD CENTERS GREATLY VALUE THE GENEROUS CONTRIBUTIONS OF THE INDIVIDUALS AND ORGANIZATIONS THAT SUPPORT OUR MISSION WITHIN THE COMMUNITY WE SERVE. IN ORDER TO ENSURE PROPER STEWARDSHIP OF OUR CHARITABLE RESOURCES, VERSITI AND ITS AFFILIATES FOLLOW A FORMALIZED PROCESS TO CONFIRM THAT COMPENSATION PROVIDED TO OUR EXECUTIVE LEADERSHIP TEAM IS FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO OTHER EXECUTIVES. THIS PROCESS ALSO HELPS US ENSURE THAT OUR COMPENSATION PROGRAM SUPPORTS THE RETENTION OF EXPERIENCED HIGHLY-QUALIFIED EXECUTIVES WHO ARE COMMITTED TO OUR MISSION. THE EXECUTIVE COMMITTEE OF THE VERSITI BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR VERSITI AND THE RELATED ENTITIES THAT IT SUPPORTS, INCLUDING VBRIF. OTHER THAN THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT. TO ENSURE THAT THE COMMITTEE IS COMPRISED OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI COMPENSATION ARRANGEMENTS, THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE VERSITI EXECUTIVE COMMITTEE REVIEWS EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. IN ORDER TO ASSESS THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS, THE EXECUTIVE COMMITTEE OBTAINS AND REVIEWS APPROPRIATE COMPARABILITY DATA COLLECTED BY THE HUMAN RESOURCE DEPARTMENT AND/OR A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT. THE EXECUTIVE COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE; AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE EXECUTIVE COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. THE COMMITTEE CHAIR VERBALLY COMMUNICATES TO THE VERSITI BOARD OF DIRECTORS A CONFIRMATION OF COMPENSATION REASONABLENESS AND TEH OVERALL DUE DILIGENCE PROCESS. VERSITI AND VERSITI WISCONSIN HAVE INCENTIVE PROGRAMS FOR EXECUTIVES, DIRECTORS, MANAGEMENT, INVESTIGATORS AND STAFF DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -EXECUTIVES - THE BOARD OF DIRECTORS HAS DELAGATED TO THE VERSITI/VERSITI WISCONSIN CEO THE PERFORMANCE ASSESSMENT AND COMPENSATION DECISIONS FOR HIS/HER TEAM AND LEADERS ELIGIBLE FOR THE VERSITI LEADERSHIP INCENTIVE PLAN. DURING THE MAY MEETING, THE EXECUTIVE COMMITTEE REVIEWS THE INCENTIVES (SHORT AND LONG-TERM) PAYOUTS AND MERIT INCREASES ASSIGNED TO THE EXECUTIVE TEAM AS PART OF THE ANNUAL COMPENSATION REASONABILITY REVIEW CONDUCTED BY AON CONSULTANTS. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES THE SALARY INCREASES AND INCENTIVE PAYOUTS OF THE CEO BEFORE PAYMENT. EXECUTIVES ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON THE: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET
PART I, LINES 5A, 5B, 6A, 6B AND 7:
NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION, THE INCENTIVE PAYOUT IS DETERMINED, IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS/OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT/CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Provenance

Return type
form_990
Tax year
2023
Filed
28 October 2024
IRS schema version
2023v5.1
Source object
202413039349301131

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.